We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.87%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$493M
AUM Growth
+$4.13M
(+0.85%)
Cap. Flow
-$34.1M
Cap. Flow
% of AUM
-6.93%
Top 10 Holdings %
Top 10 Hldgs %
38.08%
Holding
111
New
22
Increased
19
Reduced
35
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$13.5M |
| 2 |
Cigna
CI
|
+$9.96M |
| 3 |
Merck
MRK
|
+$9.66M |
| 4 |
Icon
ICLR
|
+$9.38M |
| 5 |
GSK
GSK
|
+$9.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$13.1M |
| 2 |
Cencora
COR
|
+$12.5M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$12.3M |
| 4 |
Sanofi
SNY
|
+$10.7M |
| 5 |
Amgen
AMGN
|
+$9.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.45% |
| 2 | Consumer Staples | 1.34% |
| 3 | Technology | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Orthofix Medical
OFIX
$428M
| – | – |
-138,525
| Closed | -$5.95M |
|
|
OTRK
102
DELISTED
Ontrak
OTRK
| – | – |
-425
| Closed | -$2.36M |
|
|
103
Sanofi
SNY
$104B
| – | – |
-220,201
| Closed | -$10.7M |
|
104
Varex Imaging
VREX
$516M
| – | – |
-266,740
| Closed | -$4.45M |
|
|
WBA
105
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-308,686
| Closed | -$12.3M |
|
|
VRAY
106
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-775,000
| Closed | -$2.96M |
|
|
ZSAN
107
DELISTED
Zosano Pharma Corporation
ZSAN
| – | – |
-12,215
| Closed | -$225K |
|
|
ODT
108
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-75,500
| Closed | -$1.45M |
|
|
CHAQ.U
109
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| – | – |
-400,000
| Closed | -$4.24M |
|
|
VINCW
110
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
| – | – |
-210,000
| Closed | -$693K |
|
|
GWPH
111
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-33,801
| Closed | -$3.9M |
|
Similar funds
GUB
KLI
JA
AAM
TCM
CA
SAM
ACM
Sio Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Sio Capital Management held 111 positions worth $493M, up 0.85% from $489M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Sio Capital Management withdrew a net $34.1M in Q1 2021, closing 22 positions and reducing 35 holdings. Its most notable exit was AstraZeneca, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 82% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Sio Capital Management opened a new position in Centene worth $13.9M.
- Sio Capital Management's largest Q1 2021 buy was Centene: 217,500 shares worth $13.9M.
- Sio Capital Management added most to Cigna in Q1 2021, an estimated $9.96M increase.
- Sio Capital Management's biggest Q1 2021 reduction was Curis, cutting an estimated $3.92M.
- Sio Capital Management fully exited AstraZeneca in Q1 2021, selling an estimated $13.1M.
- Sio Capital Management's ten largest holdings make up 38% of its $493M portfolio in Q1 2021.
- Sio Capital Management opened 22 new positions and closed 22 in Q1 2021.
- Sio Capital Management's portfolio value rose 0.85% quarter-over-quarter to $493M.
Based on Sio Capital Management's 13F filing for Q1 2021, filed 14 May 2021.